Ying-yi Qin - Publications

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Journal: Gut

Published: February 10, 2026

Safety of Early Oral Refeeding in Patients With Chronic Pancreatitis After Extracorporeal Shock Wave Lithotripsy of Pancreatic Stone (SHEEL): A Multicenter Randomized Controlled Trial.

Journal: The American journal of gastroenterology

Published: April 23, 2025

Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 05, 2024

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Journal: Nature medicine

Published: September 20, 2023

Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 24, 2022

Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: November 19, 2021

A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 21, 2021